Skip to content

Neuronetics STIM Debt-to-equity

Debt-to-equity at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
0.3×0.0×
LBR
LB Pharmaceuticals Inc Common StockLBRX
Stereotaxis logo
StereotaxisSTXS
0.4×-1.7×
Neuropace, Inc. logo
Neuropace, Inc.NPCE
4.9×+1.9×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.1×-0.1×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
3.4×+3.2×

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-59.6%
Enterprise value$162.64M-44.6%
P/S0.6×-1.4×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Current ratio1.7×-0.8×

Where this comes from

Calculated from Neuronetics’s reported figures.

Based on the most recent quarter.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's debt-to-equity?
Neuronetics (STIM) reported debt-to-equity of 6.4× in Q1 2026.
How has Neuronetics's debt-to-equity changed year-over-year?
Neuronetics's debt-to-equity increased by 176.5% year-over-year, from 2.3× to 6.4×.
What is the long-term trend for Neuronetics's debt-to-equity?
Over 5 years (2020 to 2025), Neuronetics's debt-to-equity has grown at a 21.8% compound annual growth rate (CAGR), from 1.5× to 4×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.